These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11520364)

  • 1. Subsequent endometrial carcinoma with adjuvant tamoxifen treatment in Japanese breast cancer patients.
    Nishimura N; Hachisuga T; Saito T; Kawarabayashi T
    Int J Gynecol Cancer; 2001; 11(4):272-6. PubMed ID: 11520364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endometrium in breast cancer patients on tamoxifen.
    Dallenbach-Hellweg G; Schmidt D; Hellberg P; Bourne T; Kreuzwieser E; Dören M; Rydh W; Rudenstam G; Granberg S
    Arch Gynecol Obstet; 2000 Apr; 263(4):170-7. PubMed ID: 10834325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
    Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.
    McCluggage WG; Sumathi VP; McManus DT
    Hum Pathol; 2003 Sep; 34(9):939-43. PubMed ID: 14562291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the epidermal growth factor system in endometrial cancer after adjuvant tamoxifen treatment for breast cancer.
    Androutsopoulos G; Adonakis G; Gkermpesi M; Gkogkos P; Ravazoula P; Kourounis G
    Eur J Gynaecol Oncol; 2006; 27(5):490-4. PubMed ID: 17139985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
    Sliwińska M; Wojtacki J; Sliwiński W
    Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    Slomovitz BM; Sun CC; Ramirez PT; Bodurka DC; Diaz P; Lu KH
    Obstet Gynecol; 2004 Aug; 104(2):255-60. PubMed ID: 15291996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
    Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen.
    Ozşener S; Ozaran A; Itil I; Dikmen Y
    Eur J Gynaecol Oncol; 1998; 19(6):580-3. PubMed ID: 10215447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.
    Matsuyama Y; Tominaga T; Nomura Y; Koyama H; Kimura M; Sano M; Miura S; Takashima S; Mitsuyama S; Ueo H; Ohashi Y
    Ann Oncol; 2000 Dec; 11(12):1537-43. PubMed ID: 11205460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine neoplasms in patients treated with tamoxifen.
    Silva EG; Tornos C; Malpica A; Mitchell MF
    J Cell Biochem Suppl; 1995; 23():179-83. PubMed ID: 8747394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G; Hahn U; Schmidt D
    Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential oncogenic effect of tamoxifen on the endometrium.
    Berlière M; Galant C; Donnez J
    Hum Reprod; 1999 May; 14(5):1381-3. PubMed ID: 10325299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen-induced endometrial cancer.
    Chen P; Yang CC; Chen YJ; Wang PH
    Eur J Gynaecol Oncol; 2003; 24(2):135-7. PubMed ID: 12701962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
    Berlière M; Charles A; Galant C; Donnez J
    Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.
    Jones ME; van Leeuwen FE; Hoogendoorn WE; Mourits MJ; Hollema H; van Boven H; Press MF; Bernstein L; Swerdlow AJ
    Breast Cancer Res; 2012 Jun; 14(3):R91. PubMed ID: 22691381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary ovarian small cell carcinoma of pulmonary type with coexisting endometrial carcinoma in a breast cancer patient receiving tamoxifen: A case report and literature review.
    Yin L; Li J; Wei Y; Ma D; Sun Y; Sun Y
    Medicine (Baltimore); 2018 Jun; 97(23):e10900. PubMed ID: 29879027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
    Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
    Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.